Neurophysiological approach to central pain modulation in primary headaches.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3452008)

Published in J Headache Pain on September 01, 2005

Authors

Paolo Rossi1, Mariano Serrao, Armando Perrotta, Francesco Pierelli, Giorgio Sandrini, Giuseppe Nappi

Author Affiliations

1: Headache Clinic, INI Grottaferrata, Via S. Anna snc, I-00046, Grottaferrata (Rome), Italy. paolo.rossi90@aliceposta.it

Associated clinical trials:

Molecular Pathways Involved in Knee Pain | NCT04443452

Articles by these authors

Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey. Cephalalgia (2012) 2.48

Spontaneous intracranial hypotension syndrome: report of twelve cases. Headache (2004) 2.26

Abnormal sensorimotor plasticity in migraine without aura patients. Pain (2013) 2.04

Sudden stopping in patients with cerebellar ataxia. Cerebellum (2013) 1.97

Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol (2008) 1.96

Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J (2009) 1.95

Olfactory hallucinations as a manifestation of hidden rhinosinusitis. J Clin Neurosci (2009) 1.91

Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain (2011) 1.75

Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain (2005) 1.74

The lower limb flexion reflex in humans. Prog Neurobiol (2005) 1.67

Diagnostic delay and suboptimal management in a referral population with hemicrania continua. Headache (2009) 1.54

Shortened cortical silent period in facial muscles of patients with migraine. Pain (2007) 1.45

Increased H-reflex response induced by intramuscular electrical stimulation of latent myofascial trigger points. Acupunct Med (2009) 1.44

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. J Neurol (2004) 1.43

Facilitated temporal processing of pain and defective supraspinal control of pain in cluster headache. Pain (2013) 1.22

Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord (2005) 1.20

Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain (2013) 1.16

REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Mov Disord (2008) 1.15

Diagnostic and therapeutic errors in cluster headache: a hospital-based study. J Headache Pain (2014) 1.14

Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Clin Biomech (Bristol, Avon) (2007) 1.11

Early and long-term outcome of rehabilitation in stroke patients: the role of patient characteristics, time of initiation, and duration of interventions. Arch Phys Med Rehabil (2003) 1.11

Italian guidelines for primary headaches: 2012 revised version. J Headache Pain (2012) 1.10

Habituation and migraine. Neurobiol Learn Mem (2008) 1.10

Habituation and sensitization in primary headaches. J Headache Pain (2013) 1.09

The XX Ottorino Rossi award. Funct Neurol (2009) 1.08

Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain (2004) 1.08

Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy. Biochem Biophys Res Commun (2008) 1.07

Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant (2009) 1.05

A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain (2009) 1.03

REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord (2006) 1.03

Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics (2002) 1.02

Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res (2009) 1.02

Relationship between recovery of calf-muscle biomechanical properties and gait pattern following surgery for achilles tendon rupture. Clin Biomech (Bristol, Avon) (2006) 1.01

Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women. Psychosom Med (2002) 1.00

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci (2007) 0.99

Nitroglycerin induces hyperalgesia in rats--a time-course study. Eur J Pharmacol (2003) 0.99

The gender effect in juvenile Huntington disease patients of Italian origin. Am J Med Genet B Neuropsychiatr Genet (2004) 0.99

Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord (2003) 0.97

Use of complementary and alternative medicine by patients with chronic tension-type headache: results of a headache clinic survey. Headache (2006) 0.97

From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries. J Headache Pain (2009) 0.97

Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Mov Disord (2006) 0.97

Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Saf (2002) 0.96

Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain (2009) 0.96

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain (2011) 0.95

Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci Lett (2002) 0.95

Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. Mov Disord (2009) 0.94

Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: a double-blind, placebo-controlled, cross-over study. Eur J Pain (2010) 0.93

De novo FTL mutation: a clinical, neuroimaging, and molecular study. Mov Disord (2012) 0.93

Muscle MRI in adult-onset acid maltase deficiency. Neuromuscul Disord (2004) 0.92

Transcranial direct current stimulation for treatment of freezing of gait: a cross-over study. Mov Disord (2014) 0.92

Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC Neurol (2010) 0.92

Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat. Neurosci Lett (2004) 0.91

Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts. Cephalalgia (2010) 0.91

Childhood and adolescent migraine: a neuropsychiatric disorder? Med Hypotheses (2011) 0.91

Chronic daily headache. Expert Rev Neurother (2008) 0.90

Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol Dis (2005) 0.90

Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim Biophys Acta (2005) 0.90

Hand somatosensory subcortical and cortical sources assessed by functional source separation: an EEG study. Hum Brain Mapp (2009) 0.90

Focus on therapy: hemicrania continua and new daily persistent headache. J Headache Pain (2010) 0.89

Lateral inhibition in visual cortex of migraine patients between attacks. J Headache Pain (2013) 0.89

An electronic diary on a palm device for headache monitoring: a preliminary experience. J Headache Pain (2012) 0.89

Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial. Funct Neurol (2004) 0.88

Gait pattern in inherited cerebellar ataxias. Cerebellum (2012) 0.88

Tolerability of the triptans: clinical implications. Drug Saf (2003) 0.88

Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. J Neurooncol (2013) 0.88

The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibility. Neurosci Lett (2009) 0.88

Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology (2005) 0.87

Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS Drugs (2007) 0.87

Pisa syndrome in Parkinson's disease: clinical, electromyographic, and radiological characterization. Mov Disord (2011) 0.87

Biomarkers of oxidation, inflammation and cartilage degradation in osteoarthritis patients undergoing sulfur-based spa therapies. Clin Biochem (2010) 0.87

Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache (2012) 0.87

Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment. Funct Neurol (2007) 0.87

Four-week trunk-specific rehabilitation treatment improves lateral trunk flexion in Parkinson's disease. Mov Disord (2010) 0.87